Michael Farbaniec

Michael Farbaniec, MD is an Assistant Professor in the Department of Medicine, Division of Cardiology at Penn State University. His research focuses on cardiovascular disease, acute myocardial infarction, heart failure, and stroke prevention, with a strong emphasis on pharmacotherapy and advanced cardiac diagnostics.

• Current Institution: Penn State University
• Department: Department of Medicine, Division of Cardiology
• Academic Rank: Assistant Professor

Research Interests: Dr. Farbaniec’s work spans cardiovascular medicine, including anti-inflammatory therapies (e.g., colchicine, spironolactone), structural heart disease (e.g., cardiac myxoma, tricuspid regurgitation), and preventive strategies for cardiovascular events. He employs systematic reviews, meta-analysis, and clinical trial methodologies to advance treatment protocols.

Recent Research Trends: His 2025 publications highlight randomized controlled trials involving colchicine and spironolactone in acute myocardial infarction, structural heart disease diagnostics, and polypill efficacy for cardiovascular prevention. Earlier works from 2024–2023 explore stroke recurrence mechanisms and pharmacological interventions.

Collaborative Networks: Dr. Farbaniec collaborates with the CLEAR Investigators and multidisciplinary teams in cardiology, neurology, and pharmacology. His work is disseminated across high-impact journals like The New England Journal of Medicine and JACC: Case Reports.